Stay updated on SBRT plus Immunotherapy in Early NSCLC Pre-Surgery Clinical Trial
Sign up to get notified when there's something new on the SBRT plus Immunotherapy in Early NSCLC Pre-Surgery Clinical Trial page.

Latest updates to the SBRT plus Immunotherapy in Early NSCLC Pre-Surgery Clinical Trial page
- Check4 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2; the Back to Top element was removed. No changes to core content, pricing, stock, or time-slot information.SummaryDifference0.2%
- Check11 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1.SummaryDifference0.2%
- Check18 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as new publications related to investigational techniques and therapies. Notably, the term 'pembrolizumab' has been reintroduced, indicating a focus on this therapeutic agent.SummaryDifference5%
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check40 days agoChange DetectedThe web page has been updated from version v2.16.10 to v2.16.11, indicating a revision in the content.SummaryDifference0.1%
- Check47 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference1%
Stay in the know with updates to SBRT plus Immunotherapy in Early NSCLC Pre-Surgery Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SBRT plus Immunotherapy in Early NSCLC Pre-Surgery Clinical Trial page.